冠状动脉疾病患者使用铷-82正电子发射断层心肌灌注显像中血管扩张剂反应的预后价值
基于多中心铷-82 PET注册研究,分析3406例接受血管扩张剂负荷心肌灌注显像的冠状动脉疾病患者,按心率与收缩压变化分为反应者、部分反应者和无反应者。中位随访1.68年,全因死亡7.9%、心源性死亡2.6%。反应者正常显像年化事件率1.22%–1.58%,部分和无反应者随缺血负荷加重年化事件率更高。
要点
- 血管扩张剂负荷铷-82 PET心肌灌注显像中的血流动力学反应可预测全因死亡。
- 反应者正常显像年化事件率为1.22%(SSS 0–3)和1.58%(左室缺血0%)。
- 部分和无反应者随缺血负荷加重年化事件率更高,部分反应者可能需额外风险分层。
核心结论
- 血管扩张剂负荷铷-82 PET心肌灌注显像中的血流动力学反应可预测全因死亡。
- 部分反应者和无反应者可能需要额外风险分层以改变患者管理。
研究设计与样本
- 基于多中心铷-82 PET注册研究,纳入3406例临床指示的静息/负荷血管扩张剂PET心肌灌注显像患者。
- 按心率与收缩压变化分为反应者(心率增加≥10次/分且收缩压下降≥10 mmHg)、部分反应者(心率或收缩压任一变化)和无反应者(心率或收缩压均无变化)。
- 主要结局为全因死亡,次要结局为心源性死亡。
- 缺血负荷采用负荷总评分(SSS)和左室缺血百分比测量。
主要发现
- 中位随访1.68年(四分位距1.17–2.55年),全因死亡7.9%(n=270),心源性死亡2.6%(n=54)。
- 反应者正常PET心肌灌注显像的年化事件率为1.22%(SSS 0–3)和1.58%(左室缺血0%)。
- 部分和无反应者随缺血负荷加重年化事件率更高。
- 严重SSS≥12和左室缺血≥10%时,部分反应者年化事件率分别为10.79%和10.36%,无反应者分别为19.4%和12.43%。
- 将SSS加入临床变量模型(NRI 42%,p<0.001)及加入反应者分类(NRI 61%,p<0.001)后患者分类改善;包含临床变量、SSS和血流动力学反应的模型具有良好区分能力(Harrell C统计量0.77[0.74–0.80])。
关键数值与推荐
- 反应者定义:心率增加≥10次/分且收缩压下降≥10 mmHg。
- 部分反应者定义:心率或收缩压任一变化。
- 无反应者定义:心率或收缩压均无变化。
临床怎么用
- 原文结论指出部分反应者和无反应者可能需要额外风险分层以改变患者管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prognostic value of positron emission tomography (PET) myocardial perfusion imaging (MPI) is well established. There is paucity of data on how the prognostic value of PET relates to the hemodynamic response to vasodilator stress. We hypothesize that inadequate hemodynamic response will affect the prognostic value of PET MPI. METHODS AND RESULTS: Using a multicenter rubidium (Rb)-82 PET registry, 3406 patients who underwent a clinically indicated rest/stress PET MPI with a vasodilator agent were analyzed. Patients were categorized as, "responders" [increase in heart rate ≥ 10 beats per minute (bpm) and decrease in systolic blood pressure (SBP) ≥10 mmHg], "partial responders" (either a change in HR or SBP), and "non-responders" (no change in HR or SBP). Primary outcome was all-cause death (ACD), and secondary outcome was cardiac death (CD). Ischemic burden was measured using summed stress score (SSS) and % left ventricular (LV) ischemia. After a median follow-up of 1.68 years (interquartile range = 1.17- 2.55), there were 7.9% (n = 270) ACD and 2.6% (n = 54) CD. Responders with a normal PET MPI had an annualized event rate (AER) of 1.22% (SSS of 0-3) and 1.58% (% LV ischemia = 0). Partial and non-responders had higher AER with worsening levels of ischemic burden. In the presence of severe SSS ≥12 and LV ischemia of ≥10%, partial responders had an AER of 10.79% and 10.36%, compared to non-responders with an AER of 19.4% and 12.43%, respectively. Patient classification was improved when SSS was added to a model containing clinical variables (NRI: 42%, p < 0.001) and responder category was added (NRI: 61%, p < 0.001). The model including clinical variables, SSS and hemodynamic response has good discrimination ability (Harrell C statistics: 0.77 [0.74-0.80]). CONCLUSION: Hemodynamic response during a vasodilator Rb-82 PET MPI is predictive of ACD. Partial and non-responders may require additional risk stratification leading to altered patient management.
引用
- Arasaratnam P, Sadreddini M, Yam Y, et al. Prognostic value of vasodilator response using rubidium-82 positron emission tomography myocardial perfusion imaging in patients with coronary artery disease. Eur J Nucl Med Mol Imaging. 2017. PMID: 29177706. doi:10.1007/s00259-017-3878-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。